Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreggs Regulatory News (GRG)

Share Price Information for Greggs (GRG)

Share Price is delayed by 15 minutes
Get Live Data
1,692.00    10.00 (0.59%)
Bid:
1,692.00
Ask:
1,695.00
Spread: 3.00 (0.177%)
Market Cap: £1.73b
GRG Live PriceLast checked at - London Stock Exchange

Intraday Greggs Share Chart

Director/PDMR Shareholding

11 Nov 2009 16:54

RNS Number : 3714C
Greggs PLC
11 November 2009
 



Financial Services Authority

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: 

Greggs plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: 

Andrew John Davison, Kathryn Claire McCann and Nicola Instone (as trustees of the Greggs Employee Benefit Trust)

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date on which the threshold is crossed or reached: 

03 November 2009

6. Date on which issuer notified:

10 November 2009

7. Threshold(s) that is/are crossed or reached: 

Below 3%

  

8. Notified details:

A: Voting rights attached to shares 

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Indirect

Direct

Indirect

ORD

GBP 0.02

3,251,113

3,251,113

3,112,623

3,112,623

2.99

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date 

Exercise/ Conversion period 

Number of voting rights instrument refers to

% of voting rights 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,112,623

2.99

  

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of 103,990,470

This notification arises on the transfer of shares to Greggs plc employees on exercise of savings related share options.

Following this notification, the total voting rights of Andrew John Davison as trustee of the Greggs Employee Benefit Trust and other trusts is 7,659,703 (7.37%)

14. Contact name:

Andrew Davison

15. Contact telephone number:

0191 211 7950

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBLBDBDUBGGCB
Date   Source Headline
27th May 202611:59 amRNSDirector/PDMR Shareholding - Amendment
19th May 20263:32 pmRNSDirector/PDMR Shareholding
13th May 20263:40 pmRNSResult of AGM
12th May 20267:00 amRNSTrading Update
30th Apr 20267:00 amRNSNotice of Trading Update
13th Apr 20267:15 amRNSAnnual Financial Report
13th Apr 20267:00 amRNS-RGreggs Publishes Sustainability Report For 2025
3rd Mar 20267:00 amRNSPreliminary Results
10th Feb 20267:00 amRNSNotice of Preliminary Results
15th Jan 20262:57 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSQ4 Trading Update
18th Dec 20257:00 amRNSNotice of Trading Update
16th Dec 20257:00 amRNSAppointment of Non-Executive Director
28th Nov 20252:45 pmRNSHolding(s) in Company
19th Nov 20254:06 pmRNSBoard Update
5th Nov 20253:29 pmRNSDirector/PDMR Shareholding
5th Nov 20253:25 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSQ3 Trading Update
15th Sep 20257:00 amRNSNotice of Trading Update
28th Aug 20257:00 amRNSBoard Update
20th Aug 202511:18 amRNSDirector/PDMR Shareholding
29th Jul 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSAppointment of Non-Executive Director
15th Jul 20257:00 amRNSNotice of Interim Results
2nd Jul 20257:00 amRNSFIRST HALF 2025 TRADING UPDATE
17th Jun 202512:29 pmRNSDirector/PDMR Shareholding
17th Jun 202512:29 pmRNSDirector/PDMR Shareholding
17th Jun 202512:27 pmRNSDirector/PDMR Shareholding
17th Jun 202511:04 amRNSDirector/PDMR Shareholding
21st May 20253:36 pmRNSResult of AGM
20th May 20257:00 amRNSTrading Update
25th Apr 20257:00 amRNSNotice of Trading Update
16th Apr 20259:43 amRNSAnnual Financial Report
16th Apr 20257:15 amRNSAnnual Financial Report
16th Apr 20257:00 amRNS-RGreggs Publishes Sustainability Report For 2024
26th Mar 20251:05 pmRNSDirector/PDMR Shareholding
26th Mar 20251:04 pmRNSDirector/PDMR Shareholding
26th Mar 202510:17 amRNSDirector/PDMR Shareholding
26th Mar 202510:14 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSPreliminary Results
6th Feb 20257:00 amRNSNotice of Preliminary Results
13th Jan 20253:15 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSQ4 Trading Update
12th Dec 20247:00 amRNSNotice of Trading Update
24th Oct 20242:04 pmRNSDirector/PDMR Shareholding
10th Oct 202410:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSQ3 Trading Update
11th Sep 20247:00 amRNSNotice of Trading Update
12th Aug 20242:15 pmRNSHolding(s) in Company
6th Aug 20244:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.